Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning.
Qu WF, Tian MX, Qiu JT, Guo YC, Tao CY, Liu WR, Tang Z, Qian K, Wang ZX, Li XY, Hu WA, Zhou J, Fan J, Zou H, Hou YY, Shi YH.
Qu WF, et al. Among authors: zou h.
Front Oncol. 2022 Aug 19;12:968202. doi: 10.3389/fonc.2022.968202. eCollection 2022.
Front Oncol. 2022.
PMID: 36059627
Free PMC article.